PT Metro Healthcare Indonesia Tbk

Jakarta Stock Exchange CARE.JK

PT Metro Healthcare Indonesia Tbk EBIT Margin for the year ending December 31, 2023: -12.06%

PT Metro Healthcare Indonesia Tbk EBIT Margin is -12.06% for the year ending December 31, 2023, a -790.16% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

PT Metro Healthcare Indonesia Tbk EBIT Margin for the year ending December 31, 2022 was -1.35%, a -127.96% change year over year.
PT Metro Healthcare Indonesia Tbk EBIT Margin for the year ending December 31, 2021 was 4.85%, a -58.24% change year over year.
PT Metro Healthcare Indonesia Tbk EBIT Margin for the year ending December 31, 2020 was 11.60%, a 885.86% change year over year.
PT Metro Healthcare Indonesia Tbk EBIT Margin for the year ending December 31, 2019 was -1.48%, a 55.48% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

Jakarta Stock Exchange: CARE.JK

PT Metro Healthcare Indonesia Tbk

CEO	Engineer Henry Kembaren M.M.
IPO Date	March 13, 2020
Location	Indonesia
Headquarters	Jl. Raya Serang Km 16,8
Employees	802
Sector	Health Care
Industries Hospitals & Clinics

Description

PT Metro Healthcare Indonesia Tbk operates and manages hospitals in Indonesia. It owns and operates 7 hospitals. The company was founded in 2015 and is based in Tangerang, Indonesia. PT Metro Healthcare Indonesia Tbk is a subsidiary of PT Anugrah Kasih Rajawali.

Key trends

Past 5 years